Literature DB >> 7695261

Nitric oxide donor-mediated killing of bioluminescent Escherichia coli.

M Virta1, M Karp, P Vuorinen.   

Abstract

The antimicrobial activities of two nitric oxide-releasing compounds against Escherichia coli were investigated by using recombinant E. coli cloned with a luciferase gene from Pyrophorus plagiophthalamus. Since luciferase uses intracellular ATP to generate visible light which can be measured from living cells in real time, we wanted to compare the extent to which cell viability parallels light emission. Results from luminescence measurements and CFU counts were in good agreement, and the decrease in light emission was shown to provide a rapid and more sensitive indication of cytotoxicity.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7695261      PMCID： PMC188284          DOI： 10.1128/AAC.38.12.2775

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  26 in total

1.  Spectral emission and quantum yield of firefly bioluminescence.

Authors:  H H SELIGER; W D McELROY
Journal:  Arch Biochem Biophys       Date:  1960-05       Impact factor: 4.013

2.  Complementary DNA coding click beetle luciferases can elicit bioluminescence of different colors.

Authors:  K V Wood; Y A Lam; H H Seliger; W D McElroy
Journal:  Science       Date:  1989-05-12       Impact factor: 47.728

3.  Bioluminescence and chemiluminescence literature. Luciferase reporter genes--lux and luc. Part 2.

Authors:  P J Hill; G S Stewart; P E Stanley
Journal:  J Biolumin Chemilumin       Date:  1993 Sep-Oct

Review 4.  A review of bioluminescent ATP techniques in rapid microbiology.

Authors:  P E Stanley
Journal:  J Biolumin Chemilumin       Date:  1989-07

5.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.

Authors:  J S Beckman; T W Beckman; J Chen; P A Marshall; B A Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

6.  Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate.

Authors:  M A Marletta; P S Yoon; R Iyengar; C D Leaf; J S Wishnok
Journal:  Biochemistry       Date:  1988-11-29       Impact factor: 3.162

7.  Vascular endothelial cells synthesize nitric oxide from L-arginine.

Authors:  R M Palmer; D S Ashton; S Moncada
Journal:  Nature       Date:  1988-06-16       Impact factor: 49.962

8.  Nitric oxide donor GEA 3162 inhibits endothelial cell-mediated oxidation of low density lipoprotein.

Authors:  U Malo-Ranta; S Ylä-Herttuala; T Metsä-Ketelä; O Jaakkola; E Moilanen; P Vuorinen; T Nikkari
Journal:  FEBS Lett       Date:  1994-01-10       Impact factor: 4.124

9.  On the mechanism of NO release from sydnonimines.

Authors:  M Feelisch; J Ostrowski; E Noack
Journal:  J Cardiovasc Pharmacol       Date:  1989       Impact factor: 3.105

10.  The spectral distribution of firefly light. II.

Authors:  W H Biggley; J E Lloyd; H H Seliger
Journal:  J Gen Physiol       Date:  1967-07       Impact factor: 4.086
View more
  7 in total

1.  Use of controlled luciferase expression to monitor chemicals affecting protein synthesis.

Authors:  J Lampinen; M Virta; M Karp
Journal:  Appl Environ Microbiol       Date:  1995-08       Impact factor: 4.792

2.  Determination of complement-mediated killing of bacteria by viability staining and bioluminescence.

Authors:  M Virta; S Lineri; P Kankaanpää; M Karp; K Peltonen; J Nuutila; E M Lilius
Journal:  Appl Environ Microbiol       Date:  1998-02       Impact factor: 4.792

3.  Nitric oxide-donating properties of mesoionic 3-aryl substituted oxatriazole-5-imine derivatives.

Authors:  H Kankaanranta; E Rydell; A S Petersson; P Holm; E Moilanen; T Corell; G Karup; P Vuorinen; S B Pedersen; A Wennmalm; T Metsä-Ketelä
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

4.  Generation of bioluminescent Streptococcus mutans and its usage in rapid analysis of the efficacy of antimicrobial compounds.

Authors:  V Loimaranta; J Tenovuo; L Koivisto; M Karp
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

5.  Recombinant luminescent bacteria for measuring bioavailable arsenite and antimonite.

Authors:  S Tauriainen; M Karp; W Chang; M Virta
Journal:  Appl Environ Microbiol       Date:  1997-11       Impact factor: 4.792

6.  Augmented inducible nitric oxide synthase expression and increased NO production reduce sepsis-induced lung injury and mortality in myeloperoxidase-null mice.

Authors:  Viktor Brovkovych; Xiao-Pei Gao; Evan Ong; Svitlana Brovkovych; Marie-Luise Brennan; Xiao Su; Stanley L Hazen; Asrar B Malik; Randal A Skidgel
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-04-18       Impact factor: 5.464

7.  Nitric oxide modulators: an emerging class of medicinal agents.

Authors:  S R Deshpande; K Satyanarayana; M N A Rao; K V Pai
Journal:  Indian J Pharm Sci       Date:  2012-11       Impact factor: 0.975
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.